Cardiology
COMPASS: Treatment Benefit of Combined Low Dose Rivaroxaban and Aspirin Preserved in Patients with Moderate Renal Impairment
A secondary analysis of the COMPASS trial showed that the benefit of combining rivaroxaban 2.5mg twice daily and aspirin is preserved in patients with moderate renal dysfunction. Dr. Keith A.A. Fox demonstrated in the study published in the Journal of the American College of Cardiology that these patients did not have an excess risk of bleeding.
